drugset / Trial / NCT06386770

Systemic Versus Local Dexmedetomidine as An Adjuvant to Bupivacaine in Ultrasound Guided Erector Spinae Block

NCT06386770

Phase 3 Unknown 75 enrolled Aswan University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this study is to investigate the analgesic effect of local versus systemic dexamedetomedine as adjuvant to bupivacaine in erector spinae block in kidney exploration surgeries.

Timeline

Start
2024-06-01
Primary completion
2025-02-25
Completion
2025-03-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.5 ug/kg Other
Comparator Dexmedetomidine Other / unclassified 0.5 ug/kg Intravenous
Comparator Bupivacaine Other / unclassified 0.25 % Other
Comparator Bupivacaine Other / unclassified 28 ml Other

Indications

No indication recorded.